AzTrials
AzTrials

HemodialysisMindfulnessNCT07471828

The Effect of Mindfulness-Based Nursing Interventions Applied to Hemodialysis Patients on Psychological Well-Being and Treatment Adherence

A study testing The intervention group received mindfulness-based nursing interventions for six weeks in people with Hemodialysis and Chronic Kidney Disease, run by Baskent University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic kidney disease (CKD) and its treatment with hemodialysis pose significant challenges to patients' psychological well-being and adherence to complex treatment regimens. This randomized controlled trial investigated the effects of nurse-led, mindfulness-based interventions on psychological well-being and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hemodialysis, Chronic Kidney Disease
What is being tested?
The intervention group received mindfulness-based nursing interventions for six weeks
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
11 Dec 2025to 26 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Voluntarily agreed to participate in the study
  • Receiving hemodialysis treatment for more than six months
  • Literate
  • 18 years of age or older

Who cannot join

  • Diagnosed severe psychiatric disorder according to DSM-5 criteria
  • Auditory, visual, or cognitive impairments that could hinder participation in the educational process
  • Withdrawal Criteria:
  • Deterioration in general health status
  • Participant's request to discontinue participation

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Baskent University

    Ankara

Other trials in Turkey (Türkiye)

About this study

Chronic kidney disease (CKD) and its treatment with hemodialysis pose significant challenges to patients' psychological well-being and adherence to complex treatment regimens. This randomized controlled trial investigated the effects of nurse-led, mindfulness-based interventions on psychological well-being and treatment adherence in patients undergoing hemodialysis. Eighty patients from a single dialysis center in Türkiye were randomly assigned to either an intervention group (n = 40) receiving six weekly mindfulness sessions or a control group (n = 40) receiving routine care. Data were collected using the Mindful Attention Awareness Scale (MAAS), the Psychological Well-Being Scale (PWB), and the End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ) at baseline and post-intervention. Mixed-design analyses revealed significant improvements in mindfulness, psychological well-being, and all subscales of treatment adherence-including hemodialysis attendance, medication adherence, fluid management, and dietary compliance-in the intervention group compared to the control group (p < 0.001). Moderate to large effect sizes (Cohen's d = 0.36-1.70) indicate clinically meaningful changes. Pearson correlation analysis demonstrated a positive association between psychological well-being and treatment adherence (r = 0.302, p < 0.01). These findings suggest that structured, nurse-delivered mindfulness programs can simultaneously enhance psychosocial outcomes and adherence behaviors in hemodialysis patients. Integrating mindfulness-based interventions into routine nursing care may provide dual benefits by promoting emotional well-being and supporting self-regulated adherence to treatment regimens. Future research should explore long-term effects, broader patient populations, and the interplay between mindfulness, self-efficacy, and other psychosocial variables to further inform patient-centered hemodialysis care.

Being tested
The intervention group received mindfulness-based nursing interventions for six weeks
Keywords
Mindfulness, Hemodialysis, Psychological Well-Being, Treatment Adherence
Medical subject headings
Renal Insufficiency, Chronic, Psychological Well-Being, Treatment Adherence and Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The intervention group received mindfulness-based nursing interventions for six weeksOther

    Also called mindfulness

    The intervention group will receive mindfulness-based nursing interventions for 6 weeks, with one session per week averaging 1 hour.

Study groups in NCT07471828
Study groupRoleWhat they receive
The Effect of Mindfulness-Based Nursing Interventions on Psychological Well-Being and Treatment AdheExperimentalBehavioral intervention, Six weekly sessions of mindfulness-based nursing interventions delivered to hemodialysis patients to improve psychological well-being and treatment adherence.
Receives: Other: The intervention group received mindfulness-based nursing interventions for six weeks
The control groupNo interventionThe control group continued to receive routine dialysis treatment and did not receive any additional education during the study period. Data collection instruments were administered at baseline and at the end of the study. After completion of the research, the educational content was shared with control group participants upon request.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mindful Attention Awareness Scale (MAAS)

    15-item scale scored on a 6-point Likert scale. Scores range from 15 to 90; higher scores indicate higher mindfulness.

    Measured: 6 weeks from baseline

  2. Psychological Well-Being Scale (PWBS)

    8-item scale scored on a 7-point Likert scale. Total scores range from 8 to 56; higher scores indicate higher psychological well-being.

    Measured: 6 weeks from baseline

  3. End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ)

    9-item questionnaire assessing hemodialysis participation, medication adherence, fluid adherence, and diet adherence. Total scores range from 0 to 1200; higher scores indicate better adherence.

    Measured: 6 weeks from baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2026
  2. Study start11 Dec 2025
  3. Primary completion26 Jan 2026
  4. Study completion26 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prior to the study, participants were informed in detail about the research, and both written and verbal informed consent were obtained. The principal investigator completed the relevant certification program before implementing the intervention. The intervention group received mindfulness-based nursing interventions for six weeks, consisting of one session per week, each lasting approximately one hour. One week after the completion of the intervention, post-test data were collected through face-to-face interviews using the data collection forms. The control group continued to receive routine dialysis treatment and did not receive any additional education during the study period. Data collection instruments were administered at baseline and at the end of the study. After completion of the research, the educational content was shared with control group participants upon request.
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07471828
Sponsor's protocol ID
KA25/443
Acronym
Mindfulness
Status last verified
Mar 2026
First submitted
3 Mar 2026
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual patient data will not be shared in order to protect participant privacy and data security. Although the data obtained within the scope of the study has been anonymized, it contains sensitive health information and will therefore only be used by the research team.

Questions about this trial

What is this clinical trial studying?

A study testing The intervention group received mindfulness-based nursing interventions for six weeks in people with Hemodialysis and Chronic Kidney Disease, run by Baskent University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mindful Attention Awareness Scale (MAAS) (time frame: 6 weeks from baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in